title: Liposomal targeting of angiogenic vasculature.
abstract: Active targeting of angiogenic vasculature represents a promising therapeutic strategy to fight a variety of diseases. In particular, attention has been focused on inhibition of tumor growth. In this review, the recent progress in targeting liposomes to angiogenic endothelial cells is discussed.
authors.affiliation: Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, PO Box 80.082, 3508 TB, Utrecht, The Netherlands. R.M.Schiffelers@pharm.uu.nl
authors.forename: Raymond M
authors.initials: RM
authors.lastname: Schiffelers
authors.forename: Marcel H A M
authors.initials: MH
authors.lastname: Fens
authors.forename: Adriënne P C A
authors.initials: AP
authors.lastname: Janssen
authors.forename: Grietje
authors.initials: G
authors.lastname: Molema
authors.forename: Gert
authors.initials: G
authors.lastname: Storm
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D009369:Neoplasms / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000473:pathology
chemical_list: D020533:Angiogenesis Inhibitors; D004337:Drug Carriers; D008081:Liposomes